Bibliografia 1. Djavan, B., Ravery, V., Zlotta, A. et al: Prospective evaluation of Prostate cancer detected on biopsies 1, 2, 3 and 4: When should we.

Slides:

Advertisements

Similar presentations

For(int i = 1; i

Advertisements

Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA

Prostate Smart Biopsy solutions UC Care Ltd. Proprietary

Prostate Cancer Detection in Men with an Initial Diagnosis of Atypical small Acinar Proliferations Dr Charles Chabert The Wollongong Hospital.

High-grade Prostatic Intraepithelial Neoplasia on Needle Biopsy Risk of Cancer on Repeat Biopsy Related to Number of Involved Cores and Morphologic Pattern.

RISK OF NON SIGNIFICANT PROSTATE CANCER IN PROSTATE CANCER PATIENTS DIAGNOSED BY AN EXTENDED PROSTATE NEEDLE BIOPSY PROCEDURE AND TREATED BY RADICAL PROSTATECTOMY.

Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.

The PCA3 Assay improves the prediction of initial biopsy outcome and may be indicative of prostate cancer aggressiveness de la Taille A, Irani J, Graefen.

بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.

Per-Anders Abrahamsson, Department of Urology Malmö University Hospital Sweden EAU, Berlin, March 24, 2007 What´s New in Prostate Cancer?

V. Scattoni Biopsia ecoguidata. Bioptic strategies: targerted biopsy.

3:00. 2:59 2:58 2:57 2:56 2:55 2:54 2:53 2:52.

What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?

Volume 56, Issue 5, Pages (November 2009)

Copyright © 1998 American Medical Association. All rights reserved.

Prostate cancer นพ.ชัชชัย หอมเกตุ.

Volume 69, Issue 3, Pages (March 2016)

Contemporary Clinical Trials

Nat. Rev. Urol. doi: /nrurol

What would you recommend?

Top Fire Protection Services Ottawa available on Dubinskyconstruction

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Figure 2 Recruitment of experts to the Delphi study

Figure 3 Semantic model of the active surveillance (AS) timeline

Nat. Rev. Urol. doi: /nrurol

Volume 61, Issue 2, Pages (February 2012)

V. Scattoni Biopsia ecoguidata.

Nomograms for Bladder Cancer

Volume 54, Issue 4, Pages (October 2008)

Elizabeth K. Bancroft, Rosalind A. Eeles

Figure 1 Key elements of the proposed modified Delphi study

Volume 69, Issue 3, Pages (March 2016)

European Urology Oncology

Prostate cancer diagnosis: should patients with prostate specific antigen >10ng/mL have stratified prostate biopsy protocols? Joe Philip, MRCSI, Ramaswamy.

Diagnostic Strategies for Prostate Cancer

Volume 56, Issue 2, Pages (August 2009)

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Figure 1 The development process of the Asian

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Volume 65, Issue 6, Pages (June 2014)

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Nat. Rev. Urol. doi: /nrurol

the SNP profile using 26 prostate cancer GWAS risk SNPs

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

PSA Levels and the Probability of Prostate Cancer on Biopsy

Thomas Steuber, Matthew Frank O'Brien, Hans Lilja European Urology

by William Hamilton, Deborah J Sharp, Tim J Peters, and Alison P Round

Nat. Rev. Urol. doi: /nrurol

Figure 4 The grey zone between active

Bob Djavan European Urology Supplements

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States Screening mammography performance metrics are.

Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes Following irreversible electroporation (IRE)

Table 1. Results of the laboratory investigations

Figure 4 Algorithm for when to determine PTEN

1) Local anesthetic 2) Dye for discography 3) 23 G discography needle 4) 18 G endoscopy needle 5) guide wire, 6 ) & 8) Triphines, 7) & 10) cannula 9) obturator.

IL6 mRNA is not detected in metastatic prostate cancer cells.

Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.

Longer testing interval may impact the outcome of a prostate biopsy following the index PSA test due to longer time for a potential tumour to grow from.

PSMA expression in pre- and posttreatment prostate carcinoma serum.

Specific reaction with MIB1, M30, and CD31 monoclonal antibodies in primary human cervical carcinoma before (A, C, and E) and after (B, D, and F) Tam treatment.

Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Mammography screening.

Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per men), among Canadian men aged 45 years.

Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy. Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy.

Prostate cancer screening beyond PSA – STHLM3 and/or MRI

Presentation transcript:

Bibliografia 1. Djavan, B., Ravery, V., Zlotta, A. et al: Prospective evaluation of Prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop?. J Urol, 166: 1679, 2001 2. Noguchi, M., Yahara, J., Koga, H. el al: Necessity of repeat biopsies in men for suspected prostate cancen. Int J Urol, 6: 7, 1999 3. Letran, J. L., Blasé, A. B., Loperiza, F. R. el al: Repeat ultrasond guided prostate needle biopsy: use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma. J Urol, 160: 426, 1998